エーザイとバイオジェン・インク、「LEQEMBI(R)」（レカネマブ）がアルツハイマー病治療薬として米国FDAよりフル承認を取得 Eisai Jul 07, 2023 09:00 JST Read More
Hitachi forms strategic research collaboration with Mass General Brigham in the field of regenerative medicine and GCT Hitachi, Ltd. Jul 06, 2023 15:52 HKT/SGT Read More
Spotlight on PX: digital tech to enable patient-centricity and agile care Clarion Events Ltd Jul 05, 2023 19:27 JST Read More
New NEURii Research Collaboration Between Eisai, Gates Ventures, Health Data Research UK, Lifearc and The University of Edinburgh to Develop Digital Solutions for Dementia is Announced Eisai Jun 30, 2023 10:08 HKT/SGT Read More
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global China Medical System Holdings Ltd. Jun 29, 2023 21:00 JST Read More
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development BioMed X Institute Jun 29, 2023 17:00 HKT/SGT Read More
エーザイ、Gates Ventures、Health Data Research UK、LifeArc、およびエジンバラ大学は認知症の課題解決に寄与するデジタル・ソリューション開発をめざす共同研究「NEURii」を開始 Eisai Jun 29, 2023 12:00 JST Read More
Eisai's "Nouknow" Will Continue to be Utilized for Brain Health Assessment as Part of The FY2023 Dementia Examination Project by Tokyo Bunkyo City Eisai Jun 22, 2023 16:08 HKT/SGT Read More
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China China Medical System Holdings Ltd. Jun 12, 2023 21:00 JST Read More
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease Eisai Jun 12, 2023 09:13 HKT/SGT Read More
エーザイ、米国FDA諮問委員会は全会一致でアルツハイマー病治療薬「LEQEMBI(R)」（レカネマブ）の臨床上のベネフィットを支持 Eisai Jun 12, 2023 09:00 JST Read More
Pilot Project for Lifelog-based Health Services in Muraoka-Fukasawa District Mitsubishi Corporation Jun 09, 2023 10:47 HKT/SGT Read More
Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer's Disease in South Korea Eisai Jun 08, 2023 12:32 HKT/SGT Read More
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、韓国において早期アルツハイマー病に係る適応で新薬承認を申請 Eisai Jun 08, 2023 09:00 JST Read More
Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses against Head and Neck Carcinoma at ASCO 2023 NEC Corporation Jun 06, 2023 14:58 HKT/SGT Read More
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision Olympus Jun 05, 2023 15:00 HKT/SGT Read More
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision Olympus Jun 05, 2023 15:00 HKT/SGT Read More
